[ Price : $8.95]
Federal Register notice: FDA announces the issuance of a priority review voucher to X4 Pharmaceuticals in response to gaining appr...[ Price : $8.95]
FDA qualifies the Assessment of IntraOcular Lens Implant Symptoms patient-reported instrument as a medical device development tool...[ Price : $8.95]
Lilly says its once-weekly insulin efsitora alfa met endpoints in two trials with insulin-nave adults with Type 2 diabetes.[ Price : $8.95]
FDA updates a Draeger Class 1 recall (device correction) of the Perseus A500 anesthesia workstation after receiving reports that t...[ Price : $8.95]
Biogen and Ionis Pharmaceuticals discontinue the development of BIIB105 (ION541), an investigational antisense oligonucleotide for...[ Price : $8.95]
CDER review chemist Andrei Ponta discusses the recent guidance on nanomaterials in drugs and biologics on a Center small business ...[ Price : $8.95]
The Sedgwick Recall Index for the first quarter of 2024 shows a drop in drug recalls and an increase in medical device recalls.[ Price : $8.95]
In an ongoing review of problems with plastic syringes made by some manufacturers in China, FDA says it has imposed an Import Aler...